biology

38Articles
biology, biotechnology, California, cambridge, crispr, Dna, Emerging-Technologies, george church, harvard university, healthcare, idinvest partners, life sciences, Massachusetts Institute of Technology, Paris, Sofinnova Partners, synthetic biology, TC, United States, University of California

DNA Script picks up $38.5 million to make DNA production faster and simpler – TechCrunch

DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big…

Artis Ventures, biology, biotechnology, crispr, CRISPR Therapeutics, Disease, Editas Medicine, Executive, genetic engineering, genetics, infection, Intellia Therapeutics, johnson & johnson, locus biosciences, North Carolina, North Carolina State University, Science, Synthego, TC, Tencent

Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies – TechCrunch

The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was…

artificial intelligence, Balderton Capital, biology, biotech, biotechnology, Boston, Dna, DNA sequencing, Europe, Fundings & Exits, generation investment management, genetics, genomics, Health, idinvest partners, Science, Sophia Genetics

Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its “data-driven medicine” – TechCrunch

Another sizeable cash injection for big data biotech: Sophia Genetics has announced a $77M Series E funding round, bringing its…

23andMe, Bio, biology, biotech, cambridge, ceo, Citizen Science, dentsu, drug discovery, funding, Harvard, Health, IBM, massachusetts, microbiology, MIT, Novartis, OS Fund, Personnel, pharmacy, San Francisco, stanford, Startups, TC, ubiome, Y Combinator

uBiome is jumping into therapeutics with a healthy $83 million in Series C financing – TechCrunch

23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market….